000			01736 a2200457 4500
005			20250514204528.0
264		0	_c20041221
008			200412s 0 0 eng d
022			_a0887-6924
024	7		_a10.1038/sj.leu.2403525 _2doi
040			_aNLM _beng _cNLM
100	1		_aVerheyden, S
245	0	0	_aIdentification of natural killer cell receptor phenotypes associated with leukemia. _h[electronic resource]
260			_bLeukemia _cDec 2004
300			_a2002-7 p. _bdigital
500			_aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAcute Disease
650	0	4	_aAntigens, CD _xmetabolism
650	0	4	_aCase-Control Studies
650	0	4	_aHumans
650	0	4	_aKiller Cells, Natural _ximmunology
650	0	4	_aLectins, C-Type _xmetabolism
650	0	4	_aLeukemia, Lymphocytic, Chronic, B-Cell _xmetabolism
650	0	4	_aLeukemia, Myeloid _xmetabolism
650	0	4	_aNK Cell Lectin-Like Receptor Subfamily C
650	0	4	_aNK Cell Lectin-Like Receptor Subfamily D
650	0	4	_aPhenotype
650	0	4	_aPolymerase Chain Reaction
650	0	4	_aPolymorphism, Single-Stranded Conformational
650	0	4	_aPrecursor Cell Lymphoblastic Leukemia-Lymphoma _xmetabolism
650	0	4	_aReceptors, Immunologic _xclassification
650	0	4	_aReceptors, KIR
650	0	4	_aReceptors, KIR2DL2
650	0	4	_aReceptors, Mitogen _xmetabolism
650	0	4	_aReceptors, Natural Killer Cell
650	0	4	_aWhite People
700	1		_aBernier, M
700	1		_aDemanet, C
773	0		_tLeukemia _gvol. 18 _gno. 12 _gp. 2002-7
856	4	0	_uhttps://doi.org/10.1038/sj.leu.2403525 _zAvailable from publisher's website
999			_c15162065 _d15162065